Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-05-15 | Mr. Jim StephensPresident of Cardiac Rhythm Management & Neuromodulation | -479,00 | 42,23k | Derivative Exercise and Sale | 88,16 | 5,85k | - |
| 2026-05-15 | Mr. Jim StephensPresident of Cardiac Rhythm Management & Neuromodulation | 1,48k | 0,00 | Derivative Exercise and Retained Stock | - | 5,85k | 33,97% |
| 2026-05-08 | Mr. Diron SmithExec. VP & CFO | -503,00 | 44,32k | Derivative Exercise and Sale | 88,12 | 12,92k | - |
| 2026-05-08 | Mr. Diron SmithExec. VP & CFO | 1,56k | 0,00 | Derivative Exercise and Retained Stock | - | 12,92k | 13,73% |
| 2026-03-31 | Mr. John HarrisExec. VP of Global Operations & Manufacturing Strategy | -1,84k | 162,10k | Derivative Exercise and Sale | 88,00 | 8,66k | - |
| 2026-03-31 | Mr. John HarrisExec. VP of Global Operations & Manufacturing Strategy | 2,00k | 0,00 | Derivative Exercise and Retained Stock | - | 8,66k | 29,95% |
| 2026-03-24 | Mr. Tony CarrExec. VP of Global Quality & Regulatory Affairs | -398,00 | 34,30k | Derivative Exercise and Sale | 86,19 | 952,00 | - |
| 2026-03-24 | Mr. Tony CarrExec. VP of Global Quality & Regulatory Affairs | 952,00 | 0,00 | Derivative Exercise and Retained Stock | - | 952,00 | - |
| 2026-03-24 | Ms. Lindsay Krause BlackwoodSenior VP, General Counsel, Chief Ethics & Compliance Officer and Corporate Secretary | -1,05k | 90,41k | Derivative Exercise and Sale | 86,19 | 2,43k | - |
| 2026-03-24 | Ms. Lindsay Krause BlackwoodSenior VP, General Counsel, Chief Ethics & Compliance Officer and Corporate Secretary | 2,43k | 0,00 | Derivative Exercise and Retained Stock | - | 2,43k | - |
| 2026-03-13 | Mr. Tom P. ThomasVP, Corporate Controller & Principal Accounting Officer | -825,00 | 70,13k | Verkauf | 85,00 | 4,38k | -15,85% |
| 2026-02-20 | Mr. Jim StephensPresident of Cardiac Rhythm Management & Neuromodulation | -656,00 | 55,66k | Sale to Issuer | 84,85 | 4,37k | -13,06% |
| 2026-02-20 | Mr. Kirk K. ThorExec. VP & Chief HR Officer | -2,20k | 186,50k | Sale to Issuer | 84,85 | 34,98k | -5,91% |
| 2026-02-20 | Mr. Tom P. ThomasVP, Corporate Controller & Principal Accounting Officer | -713,00 | 60,50k | Sale to Issuer | 84,85 | 5,21k | -12,05% |
| 2026-02-20 | Mr. Andrew SennPresident of Cardio & Vascular | -1,45k | 122,78k | Sale to Issuer | 84,85 | 14,81k | -8,90% |
| 2026-02-24 | Mr. Payman KhalesCEO, President & Director | 26,12k | 0,00 | Derivative Exercise and Retained Stock | - | 61,85k | 73,07% |
| 2026-02-24 | Mr. Payman KhalesCEO, President & Director | -16,95k | 1,48M | Derivative Exercise and Sale | 87,10 | 61,85k | - |
| 2026-02-20 | Mr. Payman KhalesCEO, President & Director | -4,64k | 393,53k | Sale to Issuer | 84,85 | 61,85k | -6,98% |
| 2026-02-20 | Mr. Diron SmithExec. VP & CFO | -394,00 | 33,43k | Sale to Issuer | 84,85 | 11,36k | -3,35% |
| 2026-01-17 | Mr. Tom P. ThomasVP, Corporate Controller & Principal Accounting Officer | 461,00 | 0,00 | Derivative Exercise and Retained Stock | - | 4,06k | 12,82% |
| 2026-01-19 | Mr. Tom P. ThomasVP, Corporate Controller & Principal Accounting Officer | -334,00 | 28,56k | Derivative Exercise and Sale | 85,15 - 85,78 | 4,06k | - |
| 2026-01-17 | Mr. Diron SmithExec. VP & CFO | 2,44k | 0,00 | Derivative Exercise and Retained Stock | - | 10,14k | 31,70% |
| 2026-01-19 | Mr. Diron SmithExec. VP & CFO | -920,00 | 78,87k | Derivative Exercise and Sale | 85,15 - 85,78 | 10,14k | - |
| 2026-01-17 | Mr. John HarrisExec. VP of Global Operations & Manufacturing Strategy | 596,00 | 0,00 | Derivative Exercise and Retained Stock | - | 6,66k | 9,83% |
| 2026-01-19 | Mr. John HarrisExec. VP of Global Operations & Manufacturing Strategy | -552,00 | 47,35k | Derivative Exercise and Sale | 85,78 | 6,66k | - |
| 2026-01-17 | Mr. Payman KhalesCEO, President & Director | 2,61k | 0,00 | Derivative Exercise and Retained Stock | - | 25,47k | 11,40% |
| 2026-01-19 | Mr. Payman KhalesCEO, President & Director | -962,00 | 82,31k | Derivative Exercise and Sale | 85,15 - 85,78 | 25,47k | - |
| 2026-01-17 | Mr. Jim StephensPresident of Cardiac Rhythm Management & Neuromodulation | 1,06k | 0,00 | Derivative Exercise and Retained Stock | - | 2,33k | 83,12% |
| 2026-01-17 | Mr. Jim StephensPresident of Cardiac Rhythm Management & Neuromodulation | -447,00 | 38,34k | Derivative Exercise and Sale | 85,78 | 2,33k | - |
| 2026-01-17 | Mr. Andrew SennPresident of Cardio & Vascular | 2,13k | 0,00 | Derivative Exercise and Retained Stock | - | 11,54k | 22,66% |
| 2026-01-19 | Mr. Andrew SennPresident of Cardio & Vascular | -1,09k | 92,62k | Derivative Exercise and Sale | 85,15 - 85,78 | 11,54k | - |
| 2026-01-17 | Mr. Kirk K. ThorExec. VP & Chief HR Officer | 1,47k | 0,00 | Derivative Exercise and Retained Stock | - | 28,16k | 5,49% |
| 2026-01-19 | Mr. Kirk K. ThorExec. VP & Chief HR Officer | -595,00 | 50,90k | Derivative Exercise and Sale | 85,15 - 85,78 | 28,16k | - |
| 2026-01-02 | Ms. Pamela G. BaileyInsider | 1,08k | 52,50k | Derivative Exercise and Retained Stock | 48,43 | 54,25k | 2,04% |
| 2026-01-02 | Ms. Pamela G. BaileyInsider | -1,80k | 52,53k | Derivative Exercise and Sale | 48,43 - 77,63 | 54,25k | - |
| 2025-12-12 | Mr. M. Craig MaxwellIndependent Director | 969,00 | 46,93k | Derivative Exercise and Retained Stock | 48,43 | 22,38k | 4,53% |
| 2025-12-12 | Mr. M. Craig MaxwellIndependent Director | -1,91k | 46,98k | Derivative Exercise and Sale | 48,43 - 72,98 | 22,38k | - |
| 2025-11-12 | Mr. John HarrisExec. VP of Global Operations & Manufacturing Strategy | 1,65k | 115,50k | Kauf | 70,00 | 6,07k | 37,36% |
| 2025-11-11 | Mr. Tom P. ThomasVP, Corporate Controller & Principal Accounting Officer | -884,00 | 62,01k | Verkauf | 70,15 | 3,60k | -19,73% |
| 2025-11-07 | Mr. Diron SmithExec. VP & CFO | 1,12k | 74,97k | Kauf | 67,19 | 7,70k | 16,95% |
| 2025-11-06 | Ms. Cheryl C. CappsIndependent Director | 1,60k | 106,72k | Kauf | 66,70 | 10,57k | 17,84% |
| 2025-10-30 | Mr. Payman KhalesCEO, President & Director | 3,13k | 203,07k | Kauf | 64,94 | 22,87k | 15,84% |
| 2025-06-11 | Mr. Joseph W. DziedzicInsider | 22,81k | 0,00 | Derivative Exercise and Retained Stock | - | 45,81k | 99,16% |
| 2025-06-11 | Mr. Joseph W. DziedzicInsider | -13,40k | 1,61M | Derivative Exercise and Sale | 120,03 | 45,81k | - |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
